Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat Plus Pembrolizumab and Chemotherapy in Metastatic NSCLC
NCT03322566Phase 2Completed
- Sponsor
- Incyte
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of epacadostat in non-small cell lung cancer (NSCLC), sponsored by Incyte. Started Jan 2018; status: completed.
02
Drugs
epacadostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03322566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322566.